Bristol-Myers Squibb Company Corp

Where the EU money came from

Funding by EU programme. Amounts are Bristol-Myers Squibb Company Corp's own share of each project, not the project's full budget.

Projects

24 EU-funded projects, newest first. Each links to the official record.

• GREGPartner

  Testing, improving, and co-creating Guidance and Tools for Real World Evidence Generation in Europe and use for Decision-Making in Europe: GREG

  Horizon Europe · 2025–2030 · Project on CORDIS ↗
• READIPartner

  REpresentative Clinical Research - ADvancing Inclusivity in Europe

  Horizon Europe · 2025–2030 · Project on CORDIS ↗
• VICT3RPartner

  Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research

  Horizon Europe · 2024–2028 · Project on CORDIS ↗
• SYNTHIAPartner

  Synthetic Data Generation Framework for Integrated Validation of Use Cases and AI Healthcare Applications

  Horizon Europe · 2024–2029 · Project on CORDIS ↗
• CLAIMSPartner

  CLinical impact through AI-assisted MS care

  Horizon Europe · 2023–2027 · Project on CORDIS ↗
• GUIDE.MRDPartner

  GUIding multi-moDal thErapies against MRD by liquid biopsies - GUIDE.MRD

  Horizon Europe · 2023–2028 · Project on CORDIS ↗
• FACILITATEPartner

  FrAmework for ClInicaL trIal participants daTA reutilization for a fully Transparent and Ethical ecosystem

  Horizon 2020 · 2022–2026 · Project on CORDIS ↗
• HIPPOCRATESPartner

  Health Initiatives in Psoriasis and PsOriatic arthritis ConsoRTium European States

  Horizon 2020 · 2021–2027 · Project on CORDIS ↗
• ARDATPartner

  Accelerating Research & Development for Advanced Therapies

  Horizon 2020 · 2020–2026 · Project on CORDIS ↗
• PREMIERPartner

  Prioritisation and Risk Evaluation of Medicines in the EnviRonment

  Horizon 2020 · 2020–2026 · Project on CORDIS ↗
• IDEA-FASTPartner

  Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases

  Horizon 2020 · 2019–2026 · Project on CORDIS ↗
• 3TRPartner

  Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

  Horizon 2020 · 2019–2028 · Project on CORDIS ↗
• ConcePTIONPartner

  Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation

  Horizon 2020 · 2019–2024 · Project on CORDIS ↗
• NECESSITYPartner

  NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients

  Horizon 2020 · 2019–2025 · Project on CORDIS ↗
• LITMUSPartner

  Liver Investigation: Testing Marker Utility in Steatohepatitis

  Horizon 2020 · 2017–2024 · Project on CORDIS ↗
• RTCurePartner

  Rheuma Tolerance for Cure

  Horizon 2020 · 2017–2023 · Project on CORDIS ↗
• IPIEPartner

  Intelligent Assessment of Pharmaceutical in the Environment

  FP7 (2007 to 2013) · 2015–2019 · Project on CORDIS ↗
• GETREALPartner

  Incorporating real-life clinical data into drug development

  FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗
• ORBITOPartner

  Oral biopharmaceutics tools

  FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗
• EUPATIPartner

  European Patients' Academy on Therapeutic Innovation

  FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗
• MIP-DILIPartner

  Mechanism-Based Integrated Systems for the Prediction of Drug-Induced Liver Injury

  FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗
• BTCUREPartner

  BeTheCuRE

  FP7 (2007 to 2013) · 2011–2017 · Project on CORDIS ↗
• GLYCOHITPartner

  Glycomics by High-throughput Integrated Technologies

  FP7 (2007 to 2013) · 2011–2014 · Project on CORDIS ↗

  €58ktheir share
• ECHOUTCOMEPartner

  European Consortium in Healthcare Outcomes and cost-benefit research

  FP7 (2007 to 2013) · 2010–2013 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Glaxosmithkline Research & Development LimitedUnited Kingdom · 15 shared projects
• Janssen Pharmaceutica NVBelgium · 14 shared projects
• Pfizer LimitedUnited Kingdom · 14 shared projects
• Novartis Pharma AGSwitzerland · 13 shared projects
• Astrazeneca ABSweden · 12 shared projects
• F. Hoffmann-La Roche AGSwitzerland · 11 shared projects
• Sanofi-Aventis Recherche & DeveloppementFrance · 11 shared projects
• Novo Nordisk A/SDenmark · 10 shared projects
• Eli Lilly and Company LtdUnited Kingdom · 9 shared projects
• Ucb BiopharmaBelgium · 9 shared projects
• Boehringer Ingelheim InternationalgmbhGermany · 9 shared projects
• Karolinska InstitutetSweden · 8 shared projects
• The University of ManchesterUnited Kingdom · 8 shared projects
• Takeda Pharmaceuticals International AGSwitzerland · 8 shared projects
• Abbvie IncUnited States · 8 shared projects
• Bayer AktiengesellschaftGermany · 7 shared projects

Fields it works in

Research fields recorded on its Horizon projects.

• HIV
• adverse drug reactions
• artificial intelligence
• autoimmune diseases
• biosensors
• cell biology
• data processing
• data protection
• databases
• diabetes
• drug discovery
• drug safety
• ecosystems
• gene therapy